RI Bio Appoints New Board Chair

Share on Social Media

Patrice Milos, PhD, has been appointed as the new board chair for RI Bio. Dr. Milos is the president/CEO and co-founder of Medley Genomics, a life sciences company dedicated to addressing the challenges of genomic heterogeneity in the diagnosis and treatment of complex diseases. Initially focused in oncology, Medley provides unique ‘molecular fingerprints’ of a patient’s cancer enabling individualized diagnosis and optimal treatment.

“Patrice is a pioneer at the interface of genomics and medicine and brings her highly innovative industry expertise and strong leadership skills to the board,” said Carol Malysz, executive director, RI Bio. “Her board leadership will help RI Bio to grow to new levels of distinction and impact in the RI life sciences community.”

Dr. Milos has served as a member of the RI Bio board since October 2017.

Latest News

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

PROVIDENCE, RI–April 26, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced their slate of NEXT WAVE events with Venture Café Providence every Thursday in May that celebrates the life sciences.  “The pandemic put advances in life sciences and...

RI Bio Board Appoints Two New Directors

RI Bio Board Appoints Two New Directors

PROVIDENCE, RI–March 16, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced the appointment of two new members to its board of directors at its March 16 meeting: Neil Sarkar of the Rhode Island Quality Institute (RIQI) and Jaimy Mauricio of...

Biotech Industry News